Surveys of Transmitted HIV Drug Resistance in 7 Geographic Regions in China, 2008–2009
Author(s) -
Lingjie Liao,
Hui Xing,
Yonghui Dong,
Guangming Qin,
Yanling Ma,
Hongyan Lu,
Lin Chen,
Lan Zhang,
Connie Osborne,
Nicole Seguy,
Daying Wei,
Feng Sun,
Juan Yang,
Yuhua Ruan,
Yiming Shao
Publication year - 2012
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cir1016
Subject(s) - medicine , human immunodeficiency virus (hiv) , drug resistance , china , resistance (ecology) , antiretroviral drug , drug , virology , hiv drug resistance , environmental health , antiretroviral therapy , pharmacology , microbiology and biotechnology , viral load , geography , biology , ecology , archaeology
In 2003, antiretroviral therapy became available free of charge in China's public health sector. During 2008 and 2009, 10 surveys to classify transmitted human immunodeficiency virus drug resistance (HIVDR) were conducted in 7 regions in 5 provinces (autonomous regions and municipalities) according to World Health Organization guidance. In 2008, transmitted HIVDR was classified as low (<5%) to nucleoside reverse-transcriptase inhibitors, nonnucleoside reverse-transcriptase inhibitors, and protease inhibitors in 6 surveys performed in 6 regions. In 2009, 3 of 4 surveys showed low rates of transmitted HIVDR to all drug classes, and 1 survey showed moderate (5%-15%) rates of transmitted protease inhibitor resistance. In China, routine surveillance of transmitted HIVDR should continue and be expanded to other regions of the country.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom